31 peer-reviewed studies · Evidence score: 5.5/10
Weiner JD et al. • Lupus science & medicine (2025)
We identified 227 herbal supplements with immunostimulatory properties, of which 15 were most strongly supported by the evidence.
Xiong X et al. • Pharmacological research (2020)
Besides, no severe adverse effects was identified by CHM.
Nasiri R et al. • Tissue & cell (2025)
Research in both animal and cell models suggests that these flavonoids, especially baicalin, can restore cardiac health following MIRI, improving cardiac performance, and reducing cardiac damage.
Chmiel M et al. • International journal of molecular sciences (2023)
In this review, we summarized the latest reports on one of the most important aglycones with respect to the pharmacological activity and high content in Baikal skullcap, which is 5,6,7-trihydroxyflavone (baicalein).
Patel S et al. • Current psychiatry reports (2024)
Evaluating benefit versus risk ratios and reviewing drug-drug interactions is essential to promote transplant candidacy and mitigate the possibility of native or graft liver dysfunction.
Tuli HS et al. • Experimental biology and medicine (Maywood, N.J.) (2023)
This review will encourage researchers to generalize the merits of wogonin to be used as potential compound for cancer treatment.
Banik K et al. • Phytotherapy research : PTR (2022)
These studies propound the use of WOG as a potential anticancer candidate; however, further high-quality studies are required to firmly establish the clinical efficacy of WOG for the prevention and treatment of human malignancies.
Enomoto Y Md et al. • Respiratory investigation (2017)
Clinicians should be cautious regarding JHM-induced pneumonitis, particularly when using drugs/ingredients known to cause this complication, and during the early treatment period.
Savage K et al. • Phytotherapy research : PTR (2018)
Collectively, the literature reveals preclinical and clinical evidence for various phytomedicines modulating GABA-pathways, with comparative anxiolytic effect to the current array of pharmaceuticals, along with good safety and tolerability profiles.
De Cola MC et al. • Brain and behavior (2018)
It is believed that cranioplasty performed from 3 to 6 months after DC may significantly improve both motor and cognitive recovery.
Huynh DL et al. • Chinese journal of natural medicines (2017)
We also summarize the potential of wogonin and its derivatives used alone or as an adjunct therapy for cancer treatment.
Ma N et al. • Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine (2016)
Medication laws of CM treatment in hypertension patientswith yin deficiency yang hyperactivity syndrome obtained by analysis of complex networks reflected thetherapeutics of nourishing yin to suppress yang, which could further provide reference for clinical studies.
Bitto A et al. • Mediators of inflammation (2014)
Flavocoxid may therefore provide a potential therapeutic approach to the treatment of chronic inflammatory conditions.
Kernbach-Wighton G et al. • Archiv fur Kriminologie (2014)
Morphology of the wounds, ballistic features and technical characteristics are discussed and the available literature is reviewed.
Bunchorntavakul C et al. • Alimentary pharmacology & therapeutics (2013)
A number of herbal medicinal products are associated with a spectrum of hepatotoxicity events.
Mo SL et al. • Combinatorial chemistry & high throughput screening (2012)
Our study has provided insights into the molecular mechanisms of interaction of synthetic and herbal compounds with human CYP2D6 and further benchmarking studies are needed to validate our modeling and virtual screening results.
Pearl PL et al. • Seminars in pediatric neurology (2011)
Herb-drug interactions also occur at the level of the P450 hepatic enzyme system of drug catabolism and the P-glycoprotein transport system regulating the entry of exogenous compounds into the vasc...
Weeks BS • Medical science monitor : international medical journal of experimental and clinical research (2009)
While questions remain in the literature regarding the medicinal value of these supplements in treating mood and anxiety disorders, based on cellular and animal studies as well as human clinical trials the literature supports a role for these preparations as useful alternatives in the management of the stress and anxiety of everyday life.
Linnebur SA et al. • Pharmacotherapy (2010)
Patients seeking dietary supplements for osteoarthritis may want to avoid glucosaminechondroitin products such as Move Free Advanced that also contain Chinese skullcap.
Yance DR Jr et al. • Integrative cancer therapies (2006)
Although controlled trials might be preferred, smaller studies with appropriate end points and surrogate markers for antiangiogenic response could help prioritize agents for the larger resource-intensive phase 3 trials.